Literature DB >> 20394650

A single, fixed dose of rasburicase (6 mg maximum) for treatment of tumor lysis syndrome in adults.

Miriam Giraldez, Katarzyna Puto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20394650     DOI： 10.1111/j.1600-0609.2010.01457.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  6 in total

1.  Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndrome.

Authors:  John Coutsouvelis; Meredith Wiseman; Lisa Hui; Susan Poole; Michael Dooley; Sushrut Patil; Sharon Avery; Andrew Wei; Andrew Spencer
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

Review 2.  The tumor lysis syndrome.

Authors:  Scott C Howard; Deborah P Jones; Ching-Hon Pui
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

Review 3.  Tumor lysis syndrome: new challenges and recent advances.

Authors:  F Perry Wilson; Jeffrey S Berns
Journal:  Adv Chronic Kidney Dis       Date:  2014-01       Impact factor: 3.620

4.  One for the road! A study to assess the efficacy of single low-dose regimen of rasburicase in controlling hyperuricaemia in patients with tumour lysis syndrome due to haematological malignancies.

Authors:  Hamdy A Azim; Sherif Ahmed Bahr; Nermine Shawky Kamal; Mohamed Adel Koura; Rehab Tolba; Heba Abdelmoneem Gad; Ahmad Morsy; Hossameldin Mohsen Attia; Ibraheem Iskander; Ahmed Hammad; Mohammed Farouk Hemed; Mohammed Fathy Abdallah; Kareem Ahmed Sadek; Alaa Hamdi Taha
Journal:  Ecancermedicalscience       Date:  2013-12-10

Review 5.  Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies.

Authors:  Ali McBride; Peter Westervelt
Journal:  J Hematol Oncol       Date:  2012-12-13       Impact factor: 17.388

Review 6.  Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy.

Authors:  Jennifer Dinnel; Bonny L Moore; Brent M Skiver; Prithviraj Bose
Journal:  Core Evid       Date:  2015-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.